These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10368798)
1. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. Leather AT; Studd JW; Watson NR; Holland EF Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis. Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632 [TBL] [Abstract][Full Text] [Related]
3. The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy. Leather AT; Studd JW; Watson NR; Holland EF Obstet Gynecol; 1993 Jan; 81(1):104-7. PubMed ID: 8416441 [TBL] [Abstract][Full Text] [Related]
4. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Mitwally MF; Gotlieb L; Casper RF Menopause; 2002; 9(4):236-41. PubMed ID: 12082359 [TBL] [Abstract][Full Text] [Related]
5. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study. Magos AL; Brincat M; Studd JW Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1629-33. PubMed ID: 3087550 [TBL] [Abstract][Full Text] [Related]
6. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome. West CP; Hillier H Hum Reprod; 1994 Jun; 9(6):1058-63. PubMed ID: 7962376 [TBL] [Abstract][Full Text] [Related]
7. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. Graham CA; Sherwin BB J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678 [TBL] [Abstract][Full Text] [Related]
8. The need for add-back with gonadotrophin-releasing hormone agonist therapy. Studd J; Leather AT Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():1-4. PubMed ID: 8916978 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. Mortola JF; Girton L; Fischer U J Clin Endocrinol Metab; 1991 Feb; 72(2):252A-252F. PubMed ID: 1846868 [TBL] [Abstract][Full Text] [Related]
10. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137 [TBL] [Abstract][Full Text] [Related]
11. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern. Lübbert H; Nauert C Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319 [TBL] [Abstract][Full Text] [Related]
12. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial. Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358 [TBL] [Abstract][Full Text] [Related]
13. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Martin V; Wernke S; Mandell K; Zoma W; Bean J; Pinney S; Liu J; Ramadan N; Rebar R Headache; 2003 Apr; 43(4):309-21. PubMed ID: 12656701 [TBL] [Abstract][Full Text] [Related]
14. Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial. Franke HR; Snaaijer FF; Houben PW; van der Mooren MJ Gynecol Endocrinol; 2006 Dec; 22(12):692-7. PubMed ID: 17162712 [TBL] [Abstract][Full Text] [Related]
15. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Watson NR; Studd JW; Savvas M; Garnett T; Baber RJ Lancet; 1989 Sep; 2(8665):730-2. PubMed ID: 2570971 [TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial. Franke HR; van de Weijer PH; Pennings TM; van der Mooren MJ Fertil Steril; 2000 Sep; 74(3):534-9. PubMed ID: 10973651 [TBL] [Abstract][Full Text] [Related]
17. Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women. Fonseca AM; Bagnoli VR; Penteado SR; Paixão JS; Cavalcanti AL; Pinotti JA Clin Drug Investig; 2007; 27(2):131-7. PubMed ID: 17217318 [TBL] [Abstract][Full Text] [Related]
18. Add-back therapy in the treatment of endometriosis: the European experience. Edmonds DK Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():10-3. PubMed ID: 8916980 [TBL] [Abstract][Full Text] [Related]
19. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis]. Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]